Therapeutic Bed Market Size was valued at USD 4.65 Billion in 2023 and is expected to reach USD 7.19 Billion by 2032, growing at a CAGR of 4.98% over the forecast period 2024-2032.
This report provides key statistical insights and emerging trends in the Therapeutic Bed Market, focusing on market volume, healthcare spending, prescription trends, and technological advancements. It analyzes the incidence and prevalence rates of medical conditions that require therapeutic beds, as well as regional market trends. The report illustrates spending trends within government, private, and out-of-pocket categories, providing insight on cost structures and what services are insured. It further covers prescription patterns demand analysis, and adoption rates under IoT and AI-based smart therapeutic beds. It explores regulatory and compliance trends driving the market across the key regions. Such insights inform key stakeholders as they navigate growth opportunities, innovations, and policy impacts in the shifting healthcare landscape. Market Dynamics and Trends of Global Therapeutic Bed The global therapeutic bed market is characterized by the increasing prevalence of chronic diseases, the growing geriatric population, and improving healthcare infrastructure.
The U.S. Therapeutic Bed Market was valued at USD 0.81 billion in 2023 and will reach USD 1.20 billion in 2032, growing at a CAGR of 5.13% during the forecast period. The National Institute of Diabetes and Digestive and Kidney Diseases estimates that around 42.7% of the U.S. population is considered obese, and 30.7% are overweight, both of which lead to more hospital admissions. The U.S. government has reported that 17.3% of its population was aged 65 or older in 2022, and that number is expected to rise to 22% by 2040. These trends in demographics and health as well as patient comfort needs for therapeutic beds are driving demand for therapeutic beds. The rising demand in hospitals, home care, and long-term care facilities driving the market. Technological advancements, increasing prevalence of chronic diseases, and rising healthcare expenditure have driven this growth and made the U.S. a key market for therapeutic beds.
Drivers
Rising healthcare expenditure globally is propelling the demand for advanced therapeutic beds as healthcare facilities invest more in patient care infrastructure.
The increasing global healthcare expenditure is a significant factor fueling the demand for sophisticated therapeutic beds. Healthcare systems allocating a greater index of resources to develop the quality of experience of patients will find it essential to invest in world-class medical equipment, be it therapeutic beds or other illness-specific devices. This trend is especially pronounced in zones with aging demographics and an increasing incidence of chronic illnesses, thereby requiring better healthcare infrastructure. For example, the United Nations reports that the global population aged 65 and above is rising quickly and that the percentage is projected to increase from 10% in 2022 to 16% in 2050. This demographic change leads to an increased prevalence of chronic diseases, which, according to WHO, represent a share of around 71% of all deaths worldwide. Hence, these factors assist the healthcare facilities to invest in therapeutic beds that are incorporated with new features to accommodate the complex requirements of geriatric patients along with chronic patients.
Technological advancements further bolster this demand. Innovations such as smart beds equipped with sensors that monitor patient vitals and adjust positioning automatically are gaining traction. These smart systems enhance patient care while also optimizing the operational efficiency of healthcare professionals. By implementing IoT technology, such work can provide real-time data capture, thereby allowing for proactive interventions.
Restraint
The high cost of advanced therapeutic beds poses a significant barrier to adoption, especially for healthcare facilities with limited budgets.
The high cost of therapeutic beds presents a significant restraint in the global healthcare market, particularly affecting institutions in developing regions. Specialty beds for these patients, which can include electronic controls and pressure redistribution mattresses, are vital components of patient care but carry significant costs. The financial strain can prevent healthcare facilities from purchasing such beds, particularly if they are working with limited budgets. In many of countries, the lack of cogent reimbursement policies is one of the main drivers of the issue. In the absence of healthcare insurance plans or government schemes, therapeutic beds remain the financial responsibility of either healthcare providers or patients. The financial burden provides minimal encouragement for the acceptance of the therapeutic bed, this is particularly the case in low LMIC where health systems are already under duress. The high upfront costs of these new beds also contribute to lengthy decision-making processes in healthcare organizations. Also, admin must balance out the upfront cost with the future payoff, which delays or leads to less capable options being chosen. Such restraint may delay the integration of innovative therapeutic beds into patient care plans and ultimately impact the quality of care received by patients.
Opportunity
The expansion of home healthcare services offers a growing market for therapeutic beds designed for residential use, catering to patients preferring in-home care.
The increase in the home healthcare service sector is a major growth opportunity for the therapeutic bed market owing to the rising demand for home-based treatment. This trend is particularly evident in the elderly and the chronically ill who want care and attention in their own houses. Recent statistics underscore this shift. The growing demand for affordable alternatives to conventional localized hospital stays and the adoption of virtual and remote care technologies.
Technology advancements are driving this market growth even more. Telemedicine and remote patient monitoring are now integrated in such a way that healthcare providers can deliver timely interventions, improve patient outcomes, and reduce overall healthcare costs. Conventional biotech devices include remote monitoring devices, which can be used to continuously check our vital signs, allowing healthcare professionals to monitor our health patterns so they can recognize abnormalities before they lead to health complications or the need for readmission to the hospital. Companies are also recognizing the potential in emerging markets. Moreover, increasing awareness of home care facilities and growing disposable income in India and China is anticipated to boost growth of the home healthcare services market. For instance, Apollo Homecare in India offers long-term plans across various categories, including orthopedic and cardiac rehabilitation, catering to the growing need for in-home medical care.
Challenge
The lack of standardization in bed designs leads to complexities for healthcare facilities in selecting appropriate therapeutic beds, hindering streamlined adoption.
The absence of standardized designs in the therapeutic bed market presents a significant challenge for healthcare facilities worldwide. This lack of uniformity results in a diverse array of bed designs, each incorporating distinct features and functionalities. As a result, hospitals and care facilities now must spend a significant amount of both time and money evaluating and selecting beds that are the best fit for their individual needs. For smaller organizations that use limited budgets and staffing, this approach can represent an overwhelming burden, which may ultimately also slow procurement and reduce the quality of care delivered to patients. The lack of standardization further complicates staff training and equipment maintenance. Healthcare providers experience bed management systems unique to each hospital with protocols for operation. This variability suggests longer training periods and a greater potential for operational errors, both of which could jeopardize patient safety. Moreover, maintenance teams struggle to provide service for the array of bed models, which necessitate distinct parts and expertise, resulting in elevated operational expenditures and equipment downtime.
By Product
The clinical beds segment accounted for approximately 47% of the therapeutic bed market in 2023, driven by their widespread use in hospitals, nursing homes, and rehabilitation centers. They are intelligent beds that enhance comfort, safety, and functionality for patients and caregivers alike. They are ideal for a variety of medical conditions ranging from post-surgery recovery to long-term treatment of chronic illnesses due to their adjustable height and tilt mechanisms.
The increasing geriatric population is one of the key factors driving the clinical beds segment. By 2040, the U.S. Census Bureau estimates that 80 million people will be 65 and older. This population growth has driven up the need for healthcare services such as clinical beds in long-term care facilities. Moreover, the increasing incidence of chronic diseases like diabetes and cardiovascular diseases has also contributed to the demand for these beds. Investment by the government in the healthcare infrastructure has also helped this segment surge. The U.S. government, for example, earmarked $10 billion in 2023 to upgrade hospitals and patient care facilities. Similar initiatives are being undertaken globally, particularly in emerging economies where healthcare systems are undergoing rapid transformation.
By Application
The acute care beds segment dominated the market and accounted for 44% revenue share in 2023 owing to its pivotal role in emergency and short-term medical care environments. Acute care beds, such as those used on trauma or surgical rows, are designated to serve patients who have been hospitalized for treatment of severe injuries, surgeries or hospitalization from a severe infection. An increasing number of acute care admissions worldwide is one of the primary growth factors for this segment. Data from the U.S. Centers for Disease Control and Prevention (CDC) show that there were over 130 million emergency department visits in 2022 alone, a substantial percentage of which needed treatment in an acute care setting. This trend points to the increasing demand for specialized beds focused on immediate care.
Government initiatives aimed at strengthening emergency healthcare services have further propelled this segment's growth. For example, the U.S. Department of Health and Human Services (HHS) announced funding of $5 billion in 2023 to expand emergency departments across hospitals in the country. Similar programs are underway in Europe and Asia–Pacific regions to strengthen critical care infrastructure. Technological advancements have also contributed significantly to this segment's expansion.
By End Use
The hospitals & clinics segment dominated the therapeutic bed market with a share of around 46% in 2023 due to its central role in delivering healthcare services across various specialties. Hospitals and clinics cater to a wide range of patients requiring inpatient and outpatient care, making therapeutic beds an essential component of their infrastructure. One major factor contributing to this segment's dominance is the high patient volume handled by hospitals globally. According to data from the American Hospital Association (AHA), U.S. hospitals recorded over 36 million admissions in 2023 alone. This high influx necessitates advanced therapeutic beds that can accommodate diverse medical needs ranging from general surgery to intensive care.
The hospitals & clinics segment was the largest end-user segment in the therapeutic bed market with 46% revenue share in 2023, supported by hospitals being a central part of delivering health care services with specialized departments. Therapeutic beds are an important segment of infrastructure that serves the needs of patients of all demographic groups requiring inpatient and outpatient care, and thus is supported by hospitals and clinics. The segment's dominance can be attributed to the high volume of patients in hospitals worldwide. Based on American Hospital Association (AHA) data, there were more than 36 million hospital admissions in the United States just in 2023. Within this large influx, we accommodate general surgery and intensive care in an advanced therapeutic bed.
Government investments have also played a pivotal role in driving this segment's growth. In 2023, several countries announced funding initiatives aimed at upgrading hospital infrastructure. For example, the Indian ministry of health set aside $1 billion through its Ayushman Bharat initiative to upgrade public hospitals with high-tech medical equipment, such as therapeutic hospital beds. Technological development has led to this segment becoming even more prominent. Therapeutic smart beds help healthcare organizations and caregivers will to a put technology to better use while leveraging benefits ranging from wireless monitoring systems with a tablet to height adjustment features and pressure-relief features to improve quality of life for patients and efficiency for caregivers. These innovations are particularly important within intensive care units (ICUs) where precision and reliability are critical.
Europe was a leading region in the therapeutic bed market with a 34% revenue share in 2023, owing to the growing aged population and the development of healthcare infrastructure. They also include massive investments in healthcare driven by countries such as Germany, France, and the UK. Germany spent EUR 480 billion on healthcare by 2023, as the country prioritized upgrading medical centers and incorporating new and improved medicinal beds. North America held a significant share, owing to high healthcare spending and advanced technologies. Millions of Americans gained access to funds to upgrade their hospital facilities through federal programs such as Medicare and Medicaid in 2023. These efforts ensure that North America continues to be a key contributor to the global therapeutic bed market.
The Asia-Pacific region exhibited the highest CAGR attributed to rapid economic development, increasing healthcare investments, and greater awareness about advanced medical technologies. Governments in countries like China and India are focusing on expanding hospital networks to meet growing patient demands. As part of its Healthy China initiative, China has confirmed its intentions to construct more than 25 new hospitals featuring advanced therapeutic beds in 2023. Moreover, favorable government policies that support public-private partnerships have further propelled the growth of the market in the Asia-Pacific. For example, India’s Ayushman Bharat program has increased the availability of affordable health care, leading to higher demand for therapeutic beds in public hospitals. The rising prevalence of chronic diseases and growing middle-class populations further contribute to regional growth.
Key Service Providers/Manufacturers
Hill-Rom Holdings, Inc. (Baxter): Centrella Smart+ Bed, Progressa Bed System
Stryker Corporation: ProCuity Bed Series, S3 MedSurg Bed
Invacare Corporation: Carroll CS Series Bed, Etude HC Bed
Medline Industries, Inc.: Alterra 1385 Hi-Low Full Electric Bed, MedLite Full Electric Bed
Arjo: Enterprise 9000X Bed, Citadel Patient Care System
Paramount Bed Holdings Co., Ltd.: A5 Series Hospital Bed, Qualitas Bed
Joerns Healthcare LLC: UltraCare XT Bed, EasyCare Bed
Drive DeVilbiss Healthcare: PrimeCare Adjustable Bed, Delta Ultra-Light 1000 Full Electric Bed
GF Health Products, Inc.: Patriot Homecare Bed, Matrix II Adjustable Bed
Span-America Medical Systems, Inc.: Encore Bed, Advantage ReadyWide Bed
LINET Group SE: Multicare Bed, Eleganza 5 Bed
Savion Industries Ltd.: Savi-Rehab Bed, Savi-Care Bed
Stiegelmeyer GmbH & Co. KG: Evario Hospital Bed, Vertica Bed
Malvestio S.p.A.: Sprint 100 Bed, Practico 25/80 Bed
Gendron, Inc.: Bariatric Care Bed, Elite Comfort Bed
Hard Manufacturing Company Inc.: Cribette Infant Bed, Youth Bed
NOA Medical Industries, Inc.: Elite Riser Bed, Bariatric Lift Bed
Transfer Master Products, Inc.: Supernal Hi-Low Bed, New Valiant Bed
APEX Medical Corp.: Domus Auto Mattress System, Serene Bed
Lojer Oy: ScanAfia X Hospital Bed, Capre E2 Examination Table
In July 2023, Alignment Health Plan expanded its services across Arizona through partnerships with local medical centers to enhance access to therapeutic care solutions.
In January 2025, Stryker Corporation launched an upgraded ProCuity bed series with integrated smart features for fall prevention and real-time monitoring.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 4.65 Billion |
| Market Size by 2032 | USD 7.19 Billion |
| CAGR | CAGR of 4.98% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Clinical Beds, Household Beds, Accessories) • By End-use (Hospital & Clinics, Reproductive Care Centers, Others) • By Application (Acute Care Beds, Critical Care Beds, Long-term Beds) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Hill-Rom Holdings, Inc. (Baxter), Stryker Corporation, Invacare Corporation, Medline Industries, Inc., Arjo, Paramount Bed Holdings Co., Ltd., Joerns Healthcare LLC, Drive DeVilbiss Healthcare, GF Health Products, Inc., Span-America Medical Systems, Inc., LINET Group SE, Savion Industries Ltd., Stiegelmeyer GmbH & Co. KG, Malvestio S.p.A., Gendron, Inc., Hard Manufacturing Company Inc., NOA Medical Industries, Inc., Transfer Master Products, Inc., APEX Medical Corp., Lojer Oy |
Ans. The projected market size for the Therapeutic Bed Market is USD 7.19 Billion by 2032.
Ans: The Europe region dominated the Therapeutic Bed Market in 2023.
Ans. The CAGR of the Therapeutic Bed Market is 4.98% During the forecast period of 2024-2032.
Ans: The high cost of advanced therapeutic beds poses a significant barrier to adoption, especially for healthcare facilities with limited budgets. ?
Ans: The Hospital & Clinics segment dominated the Therapeutic Bed Market.
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Relevant Medical Conditions (2023)
5.2 Market Volume & Growth Trends (2020-2032)
5.3 Healthcare Spending on Therapeutic Beds (2023)
5.4 Prescription Trends and Demand Analysis (2023)
5.5 Technological Innovations and Smart Bed Adoption Rates (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Therapeutic Bed Market Segmentation, By Product
7.1 Chapter Overview
7.2 Clinical Beds
7.2.1 Clinical Beds Market Trends Analysis (2020-2032)
7.2.2 Clinical Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Regular Beds
7.2.3.1 Regular Beds Market Trends Analysis (2020-2032)
7.2.3.2 Regular Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 ICU Beds
7.2.4.1 ICU Beds Market Trends Analysis (2020-2032)
7.2.4.2 ICU Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Pediatric Beds
7.2.5.1 Pediatric Beds Market Trends Analysis (2020-2032)
7.2.5.2 Pediatric Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.6 Birthing Beds
7.2.6.1 Birthing Beds Market Trends Analysis (2020-2032)
7.2.6.2 Birthing Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.7 Bariatric Beds
7.2.7.1 Bariatric Beds Market Trends Analysis (2020-2032)
7.2.7.2 Bariatric Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.8 Low Air Loss Beds
7.2.8.1 Low Air Loss Beds Market Trends Analysis (2020-2032)
7.2.8.2 Low Air Loss Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.9 Others
7.2.9.1 Others Market Trends Analysis (2020-2032)
7.2.9.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Household Beds
7.3.1 Household Beds Market Trends Analysis (2020-2032)
7.3.2 Household Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Accessories
7.4.1 Accessories Market Trends Analysis (2020-2032)
7.4.2 Accessories Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Therapeutic Bed Market Segmentation, By End-use
8.1 Chapter Overview
8.2 Hospital & Clinics
8.2.1 Hospital & Clinics Market Trends Analysis (2020-2032)
8.2.2 Hospital & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Reproductive Care Centers
8.3.1 Reproductive Care Centers Market Trends Analysis (2020-2032)
8.3.2 Reproductive Care Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Others
8.4.1 Others Market Trends Analysis (2020-2032)
8.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Therapeutic Bed Market Segmentation, By Application
9.1 Chapter Overview
9.2 Acute Care Beds
9.2.1 Acute Care Beds Market Trends Analysis (2020-2032)
9.2.2 Acute Care Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Critical Care Beds
9.3.1 Critical Care Beds Market Trends Analysis (2020-2032)
9.3.2 Critical Care Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Long-term Beds
9.4.1 Long-term Beds Market Trends Analysis (2020-2032)
9.4.2 Long-term Beds Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.4 North America Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.5 North America Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.6.2 USA Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.6.3 USA Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.7.2 Canada Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.7.3 Canada Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.2.8.2 Mexico Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.2.8.3 Mexico Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.6.2 Poland Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.6.3 Poland Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.7.2 Romania Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.7.3 Romania Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.8.2 Hungary Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.8.3 Hungary Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.9 Turkey
10.3.1.9.1 Turkey Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.9.2 Turkey Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.9.3 Turkey Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.4 Western Europe Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.5 Western Europe Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.6.2 Germany Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.6.3 Germany Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.7.2 France Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.7.3 France Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.8.2 UK Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.8.3 UK Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.9.2 Italy Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.9.3 Italy Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.10.2 Spain Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.10.3 Spain Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.13.2 Austria Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.13.3 Austria Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.4 Asia Pacific Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.5 Asia Pacific Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.6.2 China Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.6.3 China Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.7.2 India Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.7.3 India Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.8.2 Japan Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.8.3 Japan Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.9.2 South Korea Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.9.3 South Korea Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.10.2 Vietnam Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.10.3 Vietnam Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.11.2 Singapore Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.11.3 Singapore Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.12.2 Australia Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.12.3 Australia Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.4 Middle East Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.5 Middle East Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.6.2 UAE Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.6.3 UAE Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.7.2 Egypt Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.7.3 Egypt Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.9.2 Qatar Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.9.3 Qatar Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.4 Africa Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.5 Africa Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.6.2 South Africa Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.6.3 South Africa Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Therapeutic Bed Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.4 Latin America Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.5 Latin America Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.6.2 Brazil Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.6.3 Brazil Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.7.2 Argentina Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.7.3 Argentina Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.8.2 Colombia Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.8.3 Colombia Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America Therapeutic Bed Market Estimates and Forecasts, By Product (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America Therapeutic Bed Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America Therapeutic Bed Market Estimates and Forecasts, By Application (2020-2032) (USD Billion)
11. Company Profiles
11.1 Hill-Rom Holdings, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Stryker Corporation
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 Invacare Corporation
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Medline Industries, Inc.
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Arjo
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Paramount Bed Holdings Co., Ltd.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Joerns Healthcare LLC
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Drive DeVilbiss Healthcare
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 GF Health Products, Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Span-America Medical Systems, Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
By Product
Clinical Beds
Regular Beds
ICU Beds
Pediatric Beds
Birthing Beds
Bariatric Beds
Low Air Loss Beds
Others
Household Beds
Accessories
By End-use
Hospital & Clinics
Reproductive Care Centers
Others
By Application
Acute Care Beds
Critical Care Beds
Long-term Beds
Request for Segment Customization as per your Business Requirement: Segment Customization Request
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Rare Disease Genetic Testing Market was valued at USD 1.05 billion in 2023 and is expected to reach USD 3.79 billion by 2032, growing at a CAGR of 15.36% over the forecast period of 2024-2032.
The Over-The-Counter (OTC) Drugs market was USD 87.32 bn in 2023 and is projected to grow at a CAGR of 6.18%, reaching USD 149.72 bn by 2032.
The Smart Inhalers Market was valued at USD 1.63 Billion in 2023 and is estimated to reach USD 5.30 Billion by 2032 with a growing CAGR of 14.01% over the forecast period of 2024-2032.
The Infertility Treatment Market Size was USD 1.745 billion in 2023 & is expected to reach USD 3.512 Bn by 2032, growing at a CAGR of 8.02% from 2024-2032.
The Anastomosis Devices Market Size was valued at USD 3.61 billion in 2023 and is expected to reach USD 6.63 billion by 2032 and grow at a CAGR of 7.01% over the forecast period 2024-2032.
Disposable Syringes Market Size was valued at USD 14.7 Billion in 2023 and is expected to reach USD 29.06 billion by 2032, growing at a CAGR of 7.88% over the forecast period 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
